Literature DB >> 11801733

Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis.

Elke Raderschall1, Alex Bazarov, Jiangping Cao, Rudi Lurz, Avril Smith, Wolfgang Mann, Hans-Hilger Ropers, John M Sedivy, Efim I Golub, Eberhard Fritz, Thomas Haaf.   

Abstract

After exposure of mammalian cells to DNA damage, the endogenous Rad51 recombination protein is concentrated in multiple discrete foci, which are thought to represent nuclear domains for recombinational DNA repair. Overexpressed Rad51 protein forms foci and higher-order nuclear structures, even in the absence of DNA damage, in cells that do not undergo DNA replication synthesis. This correlates with increased expression of the cyclin-dependent kinase (Cdk) inhibitor p21. Following DNA damage, constitutively Rad51-overexpressing cells show reduced numbers of DNA breaks and chromatid-type chromosome aberrations and a greater resistance to apoptosis. In contrast, Rad51 antisense inhibition reduces p21 protein levels and sensitizes cells to etoposide treatment. Downregulation of p21 inhibits Rad51 foci formation in both normal and Rad51-overexpressing cells. Collectively, our results show that Rad51 expression, Rad51 foci formation and p21 expression are interrelated, suggesting a functional link between mammalian Rad51 protein and p21-mediated cell cycle regulation. This mechanism may contribute to a highly effective recombinational DNA repair in cell cycle-arrested cells and protection against DNA damage-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801733     DOI: 10.1242/jcs.115.1.153

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  39 in total

Review 1.  The consequences of Rad51 overexpression for normal and tumor cells.

Authors:  Hannah L Klein
Journal:  DNA Repair (Amst)       Date:  2008-02-01

Review 2.  Targeting the homologous recombination pathway by small molecule modulators.

Authors:  Fei Huang; Alexander V Mazin
Journal:  Bioorg Med Chem Lett       Date:  2014-05-06       Impact factor: 2.823

3.  Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C.

Authors:  Otto S Gildemeister; Jay M Sage; Kendall L Knight
Journal:  J Biol Chem       Date:  2009-09-26       Impact factor: 5.157

Review 4.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

5.  An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.

Authors:  Wenge Zhu; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.

Authors:  David Abasiwani Alagpulinsa; Shmuel Yaccoby; Srinivas Ayyadevara; Robert Joseph Shmookler Reis
Journal:  Cancer Biol Ther       Date:  2015-05-21       Impact factor: 4.742

7.  The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.

Authors:  Antonio Marzio; Joseph Puccini; Youngho Kwon; Natalia K Maverakis; Arnaldo Arbini; Patrick Sung; Dafna Bar-Sagi; Michele Pagano
Journal:  Mol Cell       Date:  2018-12-13       Impact factor: 17.970

8.  RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Authors:  Ulrica K Westermark; Nanna Lindberg; Pernilla Roswall; Daniel Bråsäter; Hildur R Helgadottir; Sanna-Maria Hede; Anders Zetterberg; Maria Jasin; Monica Nistér; Lene Uhrbom
Journal:  Neuro Oncol       Date:  2011-09-16       Impact factor: 12.300

9.  Overexpression of Drosophila Rad51 protein (DmRad51) disrupts cell cycle progression and leads to apoptosis.

Authors:  Siuk Yoo; Bruce D McKee
Journal:  Chromosoma       Date:  2004-07-15       Impact factor: 4.316

10.  Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population.

Authors:  Bartosz Mucha; Jacek Kabzinski; Adam Dziki; Karolina Przybylowska-Sygut; Andrzej Sygut; Ireneusz Majsterek; Lukasz Dziki
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.